/ /

  • linkedin
  • Increase Font
  • Sharebar

    Cosmetic iris implants dubbed ‘public safety hazard’

    New Orleans—Cosmetic iris implants were first developed in Panama, where more than 700 people received bilateral implants between 2006 and 2010, said Tal Raviv, MD, speaking at Cornea Day at ASCRS 2016.

    At the time, the implant was called the New Color Iris; it has now been replaced with the BrightOcular.

    Related: Managing infections in artificial cornea

    A medical iris implant, such as the HumanOptics, has ironically has been used in cases after the New Color Iris was explanted, he said.

    These cosmetic iris implants serve no other purpose other than to change people’s iris color.

    Functional implants, however, are designed to be placed in the capsular bag or ciliary sulcus. Cosmetic implants are placed in the anterior chamber over a healthy iris and in direct apposition to the angle structures.

    The BrightOcular, however, is being heavily marketed on the Internet, with what Dr. Raviv called misleading information. He showed an Internet “commercial” where an African American male raved about his new baby blue eyes, and how “everyone” was complimenting them, and how there was no pain and how quick the procedure was.

    More cornea: 3 steps to improve ocular health of dry eye patients

    The problem, Dr. Raviv said, is that people are buying into the hype. He cited a well-known rapper’s wife who went overseas to have the implants and how her actions is now creating a “status symbol” of sorts, with the local news only labeling the implants “controversial.”

    “These implants can cause horrific damage,” he said. “Frequently, even after these implants have been removed there is permanent, irreversible vision loss.”

    No safety studies, approvals

    At issue for corneal surgeons is that the BrightOcular has no safety studies or approvals of the implant, even though the product’s website notes there is a U.S. patent and the implant is made with FDA-approved materials which the company claims “makes it safer.” It is currently being implanted in 10 countries outside the United States and Europe.

    Editorial: Why my drug of choice is dopamine

    “Studies show severe complications, including corneal decompensation, uveitis, uncontrolled glaucoma, and cataracts,” Dr. Raviv said.

    More than 50% of the patients need secondary surgeries once the implant is removed—including Descemet’s stripping endothelial keratoplasty, penetrating keratoplasty, tube shunts or trabeculectomy, and cataract extraction.

    Refusing explantation

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results